Search research articles
Contact Us
Filters
Showing results (401-410 of 407) with videos related to
Page
of 41
Sort By:
You have reached the last page of results.
This site can display upto 407 results.
Vaccine
|
March 19, 2024
Vaccine value profile for Klebsiella pneumoniae
Ziyaad Dangor, Nicole Benson, James A Berkley, et al.
RSC Medicinal Chemistry
|
August 6, 2021
Optimization of brain-penetrant picolinamide derived leucine-rich repeat kinase 2 (LRRK2) inhibitors
Anmol Gulati, Charles S Yeung, Blair Lapointe, et al.
Journal of Medicinal Chemistry
|
September 4, 2024
Discovery and Optimization of N-Heteroaryl Indazole LRRK2 Inhibitors
Kaitlyn M Logan, Will Kaplan, Vladimir Simov, et al.
Journal of Medicinal Chemistry
|
December 30, 2021
Structure-Guided Discovery of Aminoquinazolines as Brain-Penetrant and Selective LRRK2 Inhibitors
Mitchell H Keylor, Anmol Gulati, Solomon D Kattar, et al.
Journal of Medicinal Chemistry
|
December 8, 2022
Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1<i>H</i>-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson's Disease
David A Candito, Vladimir Simov, Anmol Gulati, et al.
Annals of the Rheumatic Diseases
|
March 27, 2026
Frequency and characteristics of axial involvement in psoriatic arthritis: results from the International Multicentre AXIS Study
Murat Torgutalp, Raquel Almodovar, Valderilio F Azevedo, et al.
Lancet (London, England)
|
November 29, 2017
Universal health coverage and intersectoral action for health: key messages from Disease Control Priorities, 3rd edition
Dean T Jamison, Ala Alwan, Charles N Mock, et al.
Page
of 41
Search research articles
Search
Showing results (401-410 of 407) with videos related to
Sort By:
Page
of 41
You have reached the last page of results.
This site can display upto 407 results.
Vaccine
|
March 19, 2024
Vaccine value profile for Klebsiella pneumoniae
Ziyaad Dangor, Nicole Benson, James A Berkley, et al.
RSC Medicinal Chemistry
|
August 6, 2021
Optimization of brain-penetrant picolinamide derived leucine-rich repeat kinase 2 (LRRK2) inhibitors
Anmol Gulati, Charles S Yeung, Blair Lapointe, et al.
Journal of Medicinal Chemistry
|
September 4, 2024
Discovery and Optimization of N-Heteroaryl Indazole LRRK2 Inhibitors
Kaitlyn M Logan, Will Kaplan, Vladimir Simov, et al.
Journal of Medicinal Chemistry
|
December 30, 2021
Structure-Guided Discovery of Aminoquinazolines as Brain-Penetrant and Selective LRRK2 Inhibitors
Mitchell H Keylor, Anmol Gulati, Solomon D Kattar, et al.
Journal of Medicinal Chemistry
|
December 8, 2022
Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1<i>H</i>-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson's Disease
David A Candito, Vladimir Simov, Anmol Gulati, et al.
Annals of the Rheumatic Diseases
|
March 27, 2026
Frequency and characteristics of axial involvement in psoriatic arthritis: results from the International Multicentre AXIS Study
Murat Torgutalp, Raquel Almodovar, Valderilio F Azevedo, et al.
Lancet (London, England)
|
November 29, 2017
Universal health coverage and intersectoral action for health: key messages from Disease Control Priorities, 3rd edition
Dean T Jamison, Ala Alwan, Charles N Mock, et al.
Page
of 41